The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of...

Area of Science:

• Cardiology
• Public Health
• Clinical Implementation Science

Background:

• Dyslipidaemia significantly contributes to cardiovascular disease (CVD) burden, despite existing guidelines and therapies.
• Suboptimal guideline implementation in clinical practice is characterized by therapeutic inertia and fragmented decision-making.
• Effective management of dyslipidaemia is crucial for reducing cardiovascular morbidity and mortality.

Purpose of the Study:

• To introduce the CARDIOLIPID Plan, a novel framework for implementing guideline-based dyslipidaemia care.
• To enhance the practical application of cardiovascular risk assessment and lipid-lowering interventions.
• To address challenges in clinical practice, such as therapeutic inertia and fragmented decision-making.

Main Methods:

• The CARDIOLIPID Plan integrates comprehensive cardiovascular risk assessment (CARDIO) and personalized lipid-lowering intervention (LIPID).
• It structures these components into a sequential, clinically applicable pathway.
• The framework is based on current evidence and guideline recommendations, organized for improved clarity and usability.

Main Results:

• The plan emphasizes early and appropriate treatment intensification.
• It aims to reduce therapeutic inertia through a structured approach.
• It promotes a holistic, patient-centered strategy for cardiovascular risk management.

Conclusions:

• The CARDIOLIPID Plan provides a practical tool to bridge the gap between evidence and clinical practice in dyslipidaemia management.
• Its conceptual framework requires real-world validation to confirm its impact on treatment outcomes and CVD risk reduction.
• This approach seeks to improve the translation of scientific evidence into effective patient care.